![]() |
|
|
RH Moseley, H Smit, BG Van Solkema, W Wang and DK Meijer
Department of Internal Medicine, Veterans Affairs Medical Center, Ann Arbor, Michigan, USA.
Hepatic organic cation transport in vitro, using tetraethylammonium (TEA) as a substrate, consists of at least two steps: sinusoidal uptake is stimulated by an inside-negative membrane potential and canalicular membrane transport is mediated by organic cation:H+ exchange (Moseley et al., 1992b). In vivo, however, TEA is poorly excreted into bile. In contrast, larger, more hydrophobic organic cations, such as tributylmethylammonium (TBuMA), undergo significant hepatobiliary excretion. To better characterize hepatic organic cation transport, TBuMA transport was examined in rat canalicular liver plasma membrane (cLPM) and basolateral liver plasma membrane (bILPM) vesicles. In cLPM vesicles, under voltage-clamped conditions, an outwardly directed H+ gradient stimulated [3H]TBuMA uptake consistent with electroneutral TBuMA:H+ exchange; H(+)-dependent [3H]TBuMA uptake was not the result of a H+ diffusion potential. In the absence of a H+ gradient, intravesicular TBuMA trans-stimulated [3H]TBuMA uptake. Substrates for renal and hepatic organic cation:H+ exchange cis-inhibited H(+)- dependent [3H]TBuMA uptake. No ATP-dependent [3H]TBuMA uptake was detected in cLPM vesicles, and the P-glycoprotein substrate, daunomycin, did not cis-inhibit H(+)-dependent [3H]TBuMA uptake. Carrier-mediated [3H]TBuMA uptake exhibited saturability (Km of 0.5 mM and Vmax of 0.5 nmol/mg prot/5 s). In bILPM vesicles, in contrast, a valinomycin-induced intravesicular-negative K+ diffusion potential stimulated [3H]TBuMA uptake. These findings suggest that hepatic transport of TBuMA is similar to TEA but fundamentally different from that of P-glycoprotein substrates, indicating the involvement of at least two separate processes for the hepatobiliary excretion of organic cationic drugs.
This article has been cited by other articles:
![]() |
J. E. van Montfoort, M. Muller, G. M. M. Groothuis, D. K. F. Meijer, H. Koepsell, and P. J. Meier Comparison of ""Type I"" and ""Type II"" Organic Cation Transport by Organic Cation Transporters and Organic Anion-Transporting Polypeptides J. Pharmacol. Exp. Ther., July 1, 2001; 298(1): 110 - 115. [Abstract] [Full Text] |
||||
![]() |
C. J. Sinclair, K. D. Chi, V. Subramanian, K. L. Ward, and R. M. Green Functional expression of a high affinity mammalian hepatic choline/organic cation transporter J. Lipid Res., November 1, 2000; 41(11): 1841 - 1848. [Abstract] [Full Text] |
||||
![]() |
H. Ueda, Y. Horibe, K.-J. Kim, and V. H. L. Lee Functional Characterization of Organic Cation Drug Transport in the Pigmented Rabbit Conjunctiva Invest. Ophthalmol. Vis. Sci., March 1, 2000; 41(3): 870 - 876. [Abstract] [Full Text] |
||||
![]() |
Y.-H. Han, S.-J. Chung, and C.-K. Shim Canalicular Membrane Transport Is Primarily Responsible for the Difference in Hepatobiliary Excretion of Triethylmethylammonium and Tributylmethylammonium in Rats Drug Metab. Dispos., August 1, 1999; 27(8): 872 - 879. [Abstract] [Full Text] |
||||
![]() |
L. Zhang, W. Gorset, M. J. Dresser, and K. M. Giacomini The Interaction of n-Tetraalkylammonium Compounds with a Human Organic Cation Transporter, hOCT1 J. Pharmacol. Exp. Ther., March 1, 1999; 288(3): 1192 - 1198. [Abstract] [Full Text] |
||||
![]() |
J. W. Smit, B. Weert, A. H. Schinkel, and D. K. F. Meijer Heterologous Expression of Various P-Glycoproteins in Polarized Epithelial Cells Induces Directional Transport of Small (Type 1) and Bulky (Type 2) Cationic Drugs J. Pharmacol. Exp. Ther., July 1, 1998; 286(1): 321 - 327. [Abstract] [Full Text] |
||||
![]() |
R. H. Moseley, L. J. Zugger, and R. W. Van Dyke The Neurotoxin 1-Methyl-4-phenylpyridinium Is a Substrate for the Canalicular Organic Cation/H+ Exchanger J. Pharmacol. Exp. Ther., April 1, 1997; 281(1): 34 - 40. [Abstract] [Full Text] |
||||